Despite e-prescription: DocMorris will continue to post losses in 2024

Although online pharmacies have also had a way to redeem e-prescriptions for a year now, DocMorris is still recording losses. This is set to change.

listen Print view
DocMorris advertisement with the words: "Stay doc with dad when you go to the pharmacy for him". The father is lying sick on the sofa, the child on his cell phone.

(Image: heise online)

2 min. read

Despite strong growth in e-prescriptions, DocMorris is making high losses, but the company hopes to make a profit this year thanks to e-prescriptions. This is stated in a letter from DocMorris to investors. Additional services such as telemedicine should help. According to the company, electronic prescriptions, the e-prescription and the electronic certificate of incapacity for work would ensure "seamless digital healthcare processes". DocMorris has announced its report for the first quarter of 2025 for April 10.

Advertising from mail-order pharmacies can be seen everywhere.

According to the letter, the adjusted operating loss (EBITDA) amounted to 48.6 million Swiss francs. According to information from dpa, DocMorris justified the high operating loss to date "with the increased investments in marketing for the e-prescription in Germany". DocMorris had only recently launched a new marketing campaign entitled "Mach's dir Doc einfach".

According to DocMorris, 85 percent of e-prescriptions are filled via Cardlink. Insured persons have to hold their electronic health card to the NFC interface of their smartphone and enter an SMS code in the DocMorris app. The company first received approval for the function around a year ago, which was made possible at the insistence of online pharmacies. The average age of customers who order from DocMorris via Cardlink is 57.

Videos by heise

The letter reveals that the number of new customers for e-prescriptions has tripled in the past year and even quintupled in the last quarter. The company has also succeeded in improving customer loyalty among e-prescription customers. DocMorris was also able to achieve growth in the supply of over-the-counter medicines. DocMorris also attributed the increase in efficiency to good marketing. The Munich-based telemedicine subsidiary Teleclinic, which was acquired in 2020, doubled its turnover to CHF 11 million and its positive EBITDA contribution to around CHF 3 million. Around 2.5 million people have now downloaded the app. The company intends to provide more details on the company's forecast at a planned capital increase.

(mack)

Don't miss any news – follow us on Facebook, LinkedIn or Mastodon.

This article was originally published in German. It was translated with technical assistance and editorially reviewed before publication.